Disorder Name: MDMA or related drug dependence, including MDA, sustained partial remission
Disorder Code: 213499118
Code Range: Not specified
Class Kind: category

Standard Definition:
After a diagnosis of MDMA or related drug dependence, including MDA, and often following a treatment episode or other intervention (including self-help intervention), there is a significant reduction in consumption of MDMA or related drugs, including MDA, for more than 12 months, such that even though intermittent or continuing use of MDMA or related drugs, including MDA, has occurred during this period, the definitional requirements for dependence have not been met.

Exclusions: Episode of harmful use of MDMA or related drugs, including MDA; Harmful pattern of use of MDMA or related drugs, including MDA

Clinical Description and Diagnostic Guidelines:
Clinical Description:
After a diagnosis of MDMA or related drug dependence, including MDA, and often following a treatment episode or other intervention (including self-help intervention), there is a significant reduction in consumption of MDMA or related drugs, including MDA, for more than 12 months, such that even though intermittent or continuing use of MDMA or related drugs, including MDA, has occurred during this period, the definitional requirements for dependence have not been met.

Diagnostic Exclusion Criteria:
• Should be differentiated from: Episode of harmful use of MDMA or related drugs, including MDA
• Should be differentiated from: Harmful pattern of use of MDMA or related drugs, including MDA

Diagnostic Guidelines:
• Symptom assessment should be conducted within appropriate time frames
• Consider impact of symptoms on personal, family, social, and occupational functioning
• Evaluate symptom severity and duration
• Rule out symptoms due to substance use, medical conditions, or other psychological disorders
• Recommend use of standardized assessment tools and diagnostic criteria

Treatment Considerations:
• Develop individualized treatment plans
• Consider evidence-based treatment approaches
• Refer to specialist treatment when necessary
• Regular monitoring of treatment progress and plan adjustments

For more detailed clinical guidelines, please refer to official ICD-11 documentation.